Scripta Insights

The Press Ganey research makes one thing crystal clear: building consumer trust and loyalty in healthcare hinges on ease of access, transparency, and convenience. Pain points like appointment barriers, outdated online information, and limited scheduling options lower patient satisfaction, while AI and digital tools increasingly influence healthcare decisions. Pharmacy shopping tools like Scripta are essential to providing consumers the seamless healthcare experiences they expect and deserve. Learn how we provide transparency, improve access, and empower your members to make informed prescription choices—ensuring affordability while optimizing benefits: https://lnkd.in/e9X7p22

The wait's almost over: the World 50 Accelerator EHIR Spring Roundtables kick off tomorrow in the Big Apple! We're excited to officially welcome everyone to NYC this evening, and ready to kickstart your journey to discovering innovative employer solutions. Tonight's on us. Rx savings to follow. Ask us how we do it over cocktails. Eric Levin, Ferrin Williams, PharmD MBA, Max Hooker #World50Accelerator #Innovation #Transformation #Healthcare #Benefits #EHIR #EmployerHealth #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcareinnovation #hr

The FDA may have declared the semaglutide shortage over, but the fight for patients' access to affordable drugs is far from over. Limited distribution, pharmacy reimbursement issues, and the potential impact of lawsuits on compounding pharmacies all play a role in availability and affordability. We hope that regulatory decisions and legal actions don’t create new barriers for patients who rely on these medications. Access to GLP-1s should be about patient care—not just supply chain dynamics. https://lnkd.in/gpYNMGXK #ozempic #wegovy #semaglutide #pharmanews #drugshortage #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcare #healthcareinnovation #hr #employeebenefits

Employers have spoken. Scripta Insights has been chosen as a Presenting Innovator at next week's World 50 Accelerator EHIR Spring Roundtables in NYC! It's a tremendous honor to be invited by this prestigious group of benefits leaders who have been at the forefront of identifying innovative, transformational solutions that drive strategic priorities. ? ? We're excited to present to the “OG” cohort who has seen it all, and ready to help employers fill a critical gap in modern benefits plans with our Rx Navigation solutions. We bring unprecedented transparency to pharmacy benefits for plan sponsors and their members, redefining access, affordability and adherence in prescription management. Learn more about our solution: https://lnkd.in/e9X7p22 #World50Accelerator #Innovation #Transformation #Healthcare #Benefits #EHIR #EmployerHealth #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcareinnovation #hr

The FDA has approved Merilog (insulin-aspart-szjj), the first rapid-acting insulin biosimilar, offering the same safety and efficacy as Novolog while potentially lowering costs and increasing access for patients. As biosimilars rapidly evolve, plan sponsors must ensure their members have timely insights into all available drug options. Now's the time to start using a real-time RxNavigator that keeps up with FDA approvals and pricing shifts, helping members identify cost-saving alternatives as soon as they're available. Learn how you can stay ahead of drug market changes while giving members transparency, choice, financial relief and high-quality care at www.scriptainsights.com https://lnkd.in/e9jdE5hH #biosimilar #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcare #healthcareinnovation #hr #employeebenefits

As a company founded and driven by doctors, our Pharmacy & Therapeutics (P&T) Committee plays a pivotal role in how Scripta Insights improves patient outcomes while putting money back in their pockets. Spanning 20+ specializations, this group of medical professionals reviews clinical data, recommends clinical insights, forecasts against industry trends, and develops therapeutic protocols & policies. Meet our P&T Committee and learn more: https://lnkd.in/e_YW4xjC

Did you know that your members can potentially save on their prescriptions by switching from their current medication to a more affordable brand-name drug? Watch our video to learn how Scripta’s “New Brand” savings method can help patients treat their condition with a smaller price tag!

As Medicare policies evolve, self-funded commercial plans must stay vigilant. Potential shifts in pharmacy benefits and drug pricing could have major implications: ?? The ECAPS Act may expand pharmacists' roles, improving care access—but with new reimbursement challenges ?? Uncertainty around the IRA’s Medicare Drug Price Negotiation Program requires plan sponsors to prepare for cost and contract changes with PBMs ?? The rapid growth of GLP-1s and specialty drugs will further strain budgets, making it essential to evaluate cost containment strategies But there's a silver lining: AI-driven solutions like Scripta offer opportunities to optimize plan designs and improve medication affordability. Want to stay ahead of the curve? Learn more at www.scriptainsights.com. #Medicare #AI #CostContainment #ManagedCare #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcare #healthcareinnovation #hr #employeebenefits https://lnkd.in/e6KGJFgi

Specialty drug costs are skyrocketing—especially for rare diseases—making Specialty Pharmacy (SP) selection a critical decision for plan sponsors. While exclusive SP partnerships help manufacturers control distribution and patient experience, they often limit competition and drive up costs. Plan sponsors should assess how SP arrangements impact patient access, adherence, and overall pharmacy spend. Ensuring PBM contracts allow flexibility in sourcing high-cost therapies is key. Transparency in pricing and rebates remains a challenge, so pushing for full cost visibility is critical Ready to take control of specialty drug spending and make every pharmacy dollar count? Let’s talk. Ashley Moyer,Edward Christenson, Max Hooker, Randy Ball #SpecialtyPharmacy #pharmacy #pharmacybenefits #prescriptions #selfinsured #healthcare #healthcareinnovation #hr #employeebenefits https://lnkd.in/e4iug2Hx

The exploding popularity of GLP-1s for weight loss means that plan sponsors need to start making key decisions on how to offer these treatments efficiently and sustainably to their members. Our Chief Pharmacy Officer, Ferrin Williams, PharmD MBA gives a comprehensive look into the rapidly growing GLP-1 market, the important factors plan sponsors should consider and next steps to take. https://lnkd.in/eWaB7J42